, , , , , , , , , , , , , , , , ,

BiologicalMBLThis Substance Can Break Down Ebola’s Protective Shell … So Our Immune System Can Kill It

One off the most important substances our bodies produce to fight disease is a type of protein called a “mannose-binding lectin”.

As the Journal of Infectious Diseases notes:

Circulating mannose-binding lectin (MBL) is a first-line host defense against a wide range of viral and other pathogens.


MBL preferentially recognizes glycosylated viruses including influenza virus, human immunodeficiency virus, severe acute respiratory syndrome coronovirus (SARS-CoV), Ebola virus, and Marburg virus. It also recognizes many glycosylated gram-positive and gram-negative bacteria.

Due to genetics, different people produce different amounts of MBL:

As a result of common genetic variants, MBL serum levels in humans range from 0 to 10,000 ng/mL. Thirty percent of the human population has levels <500 ng/mL, which are associated with increased susceptibility to infections in children and immunocompromised individuals.

MBLs are not only produced by our own bodies, but also by certain plants and algae.

MBLs have shown tremendous promise in fighting SARS, RSV, HIV, Hepatitis C, general immunodeficiency, and other diseases.

Including Ebola.

Specifically, it is well-documented that MBLs bind to the outside of the Ebola virus, breaking it down so that the body’s immune system can kill it.

Certain types of blue-green and red algae contain MBLs: